Cargando…
Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1
As wear particles-induced osteolysis still remains the leading cause of early implant loosening in endoprosthetic surgery, and promotion of osteoclastogenesis by wear particles has been confirmed to be responsible for osteolysis. Therapeutic agents targeting osteoclasts formation are considered for...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133998/ https://www.ncbi.nlm.nih.gov/pubmed/27787522 http://dx.doi.org/10.1038/cddis.2016.339 |
_version_ | 1782471386442235904 |
---|---|
author | Kang, Hui Yan, Yufei Jia, Peng Yang, Kai Guo, Changjun Chen, Hao Qi, Jin Qian, Niandong Xu, Xing Wang, Fei Li, Changwei Guo, Lei Deng, Lianfu |
author_facet | Kang, Hui Yan, Yufei Jia, Peng Yang, Kai Guo, Changjun Chen, Hao Qi, Jin Qian, Niandong Xu, Xing Wang, Fei Li, Changwei Guo, Lei Deng, Lianfu |
author_sort | Kang, Hui |
collection | PubMed |
description | As wear particles-induced osteolysis still remains the leading cause of early implant loosening in endoprosthetic surgery, and promotion of osteoclastogenesis by wear particles has been confirmed to be responsible for osteolysis. Therapeutic agents targeting osteoclasts formation are considered for the treatment of wear particles-induced osteolysis. In the present study, we demonstrated for the first time that desferrioxamine (DFO), a powerful iron chelator, could significantly alleviate osteolysis in an ultrahigh-molecular-weight polyethylene (UHMWPE) particles-induced mice calvaria osteolysis model. Furthermore, DFO attenuated calvaria osteolysis by restraining enhanced inflammatory osteoclastogenesis induced by UHMWPE particles. Consistent with the in vivo results, we found DFO was also able to inhibit osteoclastogenesis in a dose-dependent manner in vitro, as evidenced by reduction of osteoclasts formation and suppression of osteoclast specific genes expression. In addition, DFO dampened osteoclasts differentiation and formation at early stage but not at late stage. Mechanistically, the reduction of osteoclastogenesis by DFO was due to increased heme oxygenase-1 (HO-1) expression, as decreased osteoclasts formation induced by DFO was significantly restored after HO-1 was silenced by siRNA, while HO-1 agonist COPP treatment enhanced DFO-induced osteoclastogenesis inhibition. In addition, blocking of p38 mitogen-activated protein kinase (p38MAPK) signaling pathway promoted DFO-induced HO-1 expression, implicating that p38 signaling pathway was involved in DFO-mediated HO-1 expression. Taken together, our results suggested that DFO inhibited UHMWPE particles-induced osteolysis by restraining inflammatory osteoclastogenesis through upregulation of HO-1 via p38MAPK pathway. Thus, DFO might be used as an innovative and safe therapeutic alternative for treating wear particles-induced aseptic loosening. |
format | Online Article Text |
id | pubmed-5133998 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51339982016-12-16 Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 Kang, Hui Yan, Yufei Jia, Peng Yang, Kai Guo, Changjun Chen, Hao Qi, Jin Qian, Niandong Xu, Xing Wang, Fei Li, Changwei Guo, Lei Deng, Lianfu Cell Death Dis Original Article As wear particles-induced osteolysis still remains the leading cause of early implant loosening in endoprosthetic surgery, and promotion of osteoclastogenesis by wear particles has been confirmed to be responsible for osteolysis. Therapeutic agents targeting osteoclasts formation are considered for the treatment of wear particles-induced osteolysis. In the present study, we demonstrated for the first time that desferrioxamine (DFO), a powerful iron chelator, could significantly alleviate osteolysis in an ultrahigh-molecular-weight polyethylene (UHMWPE) particles-induced mice calvaria osteolysis model. Furthermore, DFO attenuated calvaria osteolysis by restraining enhanced inflammatory osteoclastogenesis induced by UHMWPE particles. Consistent with the in vivo results, we found DFO was also able to inhibit osteoclastogenesis in a dose-dependent manner in vitro, as evidenced by reduction of osteoclasts formation and suppression of osteoclast specific genes expression. In addition, DFO dampened osteoclasts differentiation and formation at early stage but not at late stage. Mechanistically, the reduction of osteoclastogenesis by DFO was due to increased heme oxygenase-1 (HO-1) expression, as decreased osteoclasts formation induced by DFO was significantly restored after HO-1 was silenced by siRNA, while HO-1 agonist COPP treatment enhanced DFO-induced osteoclastogenesis inhibition. In addition, blocking of p38 mitogen-activated protein kinase (p38MAPK) signaling pathway promoted DFO-induced HO-1 expression, implicating that p38 signaling pathway was involved in DFO-mediated HO-1 expression. Taken together, our results suggested that DFO inhibited UHMWPE particles-induced osteolysis by restraining inflammatory osteoclastogenesis through upregulation of HO-1 via p38MAPK pathway. Thus, DFO might be used as an innovative and safe therapeutic alternative for treating wear particles-induced aseptic loosening. Nature Publishing Group 2016-10 2016-10-27 /pmc/articles/PMC5133998/ /pubmed/27787522 http://dx.doi.org/10.1038/cddis.2016.339 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ Cell Death and Disease is an open-access journal published by Nature Publishing Group. This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Original Article Kang, Hui Yan, Yufei Jia, Peng Yang, Kai Guo, Changjun Chen, Hao Qi, Jin Qian, Niandong Xu, Xing Wang, Fei Li, Changwei Guo, Lei Deng, Lianfu Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 |
title | Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 |
title_full | Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 |
title_fullStr | Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 |
title_full_unstemmed | Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 |
title_short | Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 |
title_sort | desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133998/ https://www.ncbi.nlm.nih.gov/pubmed/27787522 http://dx.doi.org/10.1038/cddis.2016.339 |
work_keys_str_mv | AT kanghui desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT yanyufei desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT jiapeng desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT yangkai desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT guochangjun desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT chenhao desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT qijin desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT qianniandong desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT xuxing desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT wangfei desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT lichangwei desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT guolei desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 AT denglianfu desferrioxaminereducesultrahighmolecularweightpolyethyleneinducedosteolysisbyrestraininginflammatoryosteoclastogenesisviahemeoxygenase1 |